Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lansigan, Erick
6  Ergebnisse:
Personensuche X
?
1

Acute myeloid leukemia cutis with KMT2A::MLLT3 fusion prese..:

Wankel, Bret ; Afzal, Muhammad ; Loo, Eric Y....
Leukemia Research Reports.  21 (2024)  - p. 100400 , 2024
Link: https://doi.org/10.1016/..
 
?
2

The Impact of Age on Survival in CLL Patients Receiving Ibr..:

Ujjani, Chaitra ; Mato, Anthony ; Hill, Brian T...
Blood and Lymphatic Cancer: Targets and Therapy.  10 (2020)  - p. 1-5 , 2020
Link: https://doi.org/10.2147/..
 
?
3

Comparative analysis of targeted novel therapies in relapse..:

Eyre, Toby A. ; Lamanna, Nicole ; Roeker, Lindsey E....
Haematologica.  106 (2020)  1 - p. 284-287 , 2020
Link: https://doi.org/10.3324/..
 
?
4

Phase I Trial of Infusional Cyclophosphamide, Doxorubicin, ..:

Sparano, Joseph A. ; Negassa, Abdissa ; Lansigan, Erick...
Medical Oncology.  22 (2005)  3 - p. 257-268 , 2005
Link: https://doi.org/10.1385/..
 
?
5

Comparative analysis of targeted novel therapies in relapse..:

Eyre, Toby A ; Lamanna, Nicole ; Roeker, Lindsey E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776352/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

Acute myeloid leukemia cutis with KMT2A::MLLT3 fusion prese..:

Bret Wankel ; Muhammad Afzal ; Eric Y. Loo...
http://www.sciencedirect.com/science/article/pii/S2213048923000407.  , 1481
Link: https://doi.org/10.1016/..
 
1-6